NOS2 Gene
Pathway Diagram
flowchart TD
NOS2["NOS2"]:::central
NO_Production["Nitric Oxide Production"]:::pathological
Inflammation["Inflammation"]:::pathological
RELA["RELA/NF-kappaB"]:::regulatory
STAT3["STAT3"]:::regulatory
CCL3["CCL3 Chemokine"]:::pathological
HMOX1["HMOX1"]:::protective
FOXP3["FOXP3"]:::regulatory
MMP2["MMP2"]:::protective
MMP9["MMP9"]:::protective
ICAM1["ICAM1"]:::pathological
Angiogenesis["Angiogenesis"]:::protective
Neurodegeneration["Neurodegeneration"]:::pathological
MS["Multiple Sclerosis"]:::pathological
NOS2 -->|"produces"| NO_Production
NO_Production -->|"promotes"| Inflammation
NOS2 -->|"regulates"| RELA
NOS2 -->|"regulates"| STAT3
RELA -->|"enhances"| Inflammation
STAT3 -->|"modulates"| Inflammation
NOS2 -->|"regulates"| CCL3
CCL3 -->|"recruits immune cells"| Inflammation
NOS2 -->|"regulates"| HMOX1
NOS2 -->|"regulates"| FOXP3
NOS2 -->|"inhibits"| MMP2
NOS2 -->|"inhibits"| MMP9
NOS2 -->|"inhibits"| ICAM1
NOS2 -->|"inhibits"| Angiogenesis
Inflammation -->|"contributes to"| Neurodegeneration
Inflammation -->|"drives"| MS
classDef central fill:#006494,color:#e0e0e0
classDef protective fill:#1b5e20,color:#e0e0e0
classDef pathological fill:#ef5350,color:#0d0d1a
classDef regulatory fill:#4a1a6b,color:#e0e0e0
Introduction
Nos2 Nitric Oxide Synthase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...NOS2 Gene
Pathway Diagram
Mermaid diagram (expand to render)
Introduction
Nos2 Nitric Oxide Synthase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@aktan2004]
<table> [@stewart2000]
<tr><th colspan="2" style="background:#f0f0f0;">Gene Overview</th></tr> [@huang2020]
<tr><td><strong>Gene Symbol</strong></td><td>NOS2</td></tr> [@xie1992]
<tr><td><strong>Full Name</strong></td><td>Nitric Oxide Synthase 2</td></tr> [@guix2021]
<tr><td><strong>Chromosomal Location</strong></td><td>17q11.2</td></tr> [@liu2023]
<tr><td><strong>Protein Product</strong></td><td>Inducible Nitric Oxide Synthase (iNOS)</td></tr> [@saha2019]
<tr><td><strong>Molecular Weight</strong></td><td>~131 kDa</td></tr>
<tr><td><strong>Gene Family</strong></td><td>Nitric oxide synthase family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">125 edges</a></td>
</tr>
</table>
</div>
Overview
The NOS2 gene encodes inducible nitric oxide synthase (iNOS), a key enzyme responsible for producing nitric oxide (NO) in response to inflammatory stimuli. Unlike the other NOS isoforms (nNOS and eNOS), iNOS is not constitutively expressed but is induced by cytokines, bacterial lipopolysaccharides (LPS), and other inflammatory signals. Once induced, iNOS can produce large amounts of NO for extended periods, making it a critical mediator of the immune response and inflammatory diseases.
Gene Structure
The NOS2 gene spans approximately 37 kb and consists of 26 exons. The promoter region contains multiple transcription factor binding sites, including [NF-κB](/entities/nf-kb), STAT-1, AP-1, and CREB, which mediate its induction by inflammatory stimuli. Several polymorphisms in the NOS2 promoter have been associated with altered susceptibility to inflammatory and neurodegenerative diseases.
Protein Structure
iNOS is a homodimeric enzyme, with each monomer containing:
- N-terminal oxygenase domain: Binds heme (Fe-protoporphyrin IX), tetrahydrobiopterin (BH4), and L-arginine
- C-terminal reductase domain: Contains FMN, FAD, and NADPH binding sites
- Calmodulin-binding domain: iNOS is constitutively bound to calmodulin, unlike nNOS and eNOS which require calcium/calmodulin for activation
The dimerization of iNOS is essential for catalytic activity, as the oxygenase domains from each monomer form a functional active site.
Normal Function
In the immune system, iNOS-mediated NO production serves several critical functions:
Antimicrobial defense: NO and its reactive nitrogen intermediates (RNI) kill bacteria, viruses, fungi, and parasites
Immune regulation: NO modulates T-cell function, macrophage activation, and cytokine production
Vasodilation: NO produced by immune cells contributes to increased blood flow during inflammation
Signal transduction: NO acts as a signaling molecule, affecting gene expression through s-nitrosylationIn the brain, iNOS is expressed in astrocytes, [microglia](/entities/microglia), and neurons in response to injury or disease.
Expression Pattern
iNOS expression is highly inducible in:
- Macrophages and [microglia](/cell-types/microglia-neuroinflammation): Primary immune cells expressing iNOS
- [Astrocytes](/entities/astrocytes): Reactive astrocytes in injured brain
- [Neurons](/entities/neurons): Certain neuronal populations under pathological conditions
- Endothelial cells: During inflammatory responses
- hepatocytes: In response to cytokines
Expression is controlled at multiple levels: transcriptional induction, mRNA stability, and protein stability.
Role in Disease
Alzheimer's Disease
- iNOS is upregulated in AD brain, particularly around amyloid plaques
- Excessive NO production contributes to oxidative stress and nitrative damage
- NO interacts with [Aβ](/proteins/amyloid-beta) to form toxic species
- iNOS deficiency reduces amyloid pathology in mouse models
- Therapeutic targeting: iNOS inhibitors in development
Parkinson's Disease
- Increased iNOS expression in substantia nigra of PD patients
- NO contributes to dopaminergic neuron death through:
- Mitochondrial dysfunction
- Protein nitration
- DNA damage
- Inflammation-induced iNOS exacerbates MPTP toxicity
- iNOS knockout mice show protected dopaminergic neurons
Amyotrophic Lateral Sclerosis
- iNOS elevated in ALS spinal cord and motor [cortex](/brain-regions/cortex)
- NO contributes to motor neuron injury through oxidative damage
- Astrocytic iNOS may propagate neuroinflammation
- Correlation with disease progression
Multiple Sclerosis
- iNOS critical for demyelination and axonal injury
- NO produced by activated microglia damages oligodendrocytes
- iNOS inhibition reduces disease severity in EAE model
- Therapeutic potential of iNOS modulators
Stroke and Brain Injury
- iNOS induced after ischemic injury
- NO contributes to excitotoxic damage
- Timing-dependent effects (early vs. late iNOS)
- iNOS deletion reduces infarct size
Therapeutic Implications
| Approach | Status | Notes |
|----------|--------|-------|
| iNOS inhibitors | Preclinical | L-NIL, 1400W showing promise |
| NOS isoform-selective | Research | Avoiding eNOS/nNOS inhibition |
| BH4 supplementation | Research | Co-factor availability |
| Antioxidants | Clinical | Indirectly reduce NO toxicity |
| Anti-inflammatory | Clinical | Reduce iNOS induction |
Animal Models
- NOS2 knockout mice: Used to study iNOS function in disease models
- iNOS transgenic mice: Overexpression models for neuroinflammation
- Conditioned iNOS mice: Inducible expression systems
Key Research Directions
isoform-selective inhibitors: Developing drugs that specifically target iNOS without affecting nNOS/eNOS
[Blood-brain barrier](/entities/blood-brain-barrier) penetration: Improving delivery of iNOS inhibitors to CNS
Timing of intervention: Understanding the temporal role of NO in disease progression
Biomarker development: NO metabolites as disease markers
Gene therapy: Targeted delivery of iNOS modulatorsBackground
The study of Nos2 Nitric Oxide Synthase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Stroke](/diseases/stroke)
- Nitric Oxide Signaling
- [Microglia](/cell-types/microglia)
- [Astrocytes](/cell-types/astrocytes)
External Links
- [NCBI Gene: NOS2](https://www.ncbi.nlm.nih.gov/gene/4843)
- [UniProt: P70689](https://www.uniprot.org/uniprot/P70689)
- [Human Protein Atlas](https://www.proteinatlas.org/)
References
[Nathan C, Xie QW, Nitric oxide synthases: roles, tolls, and controls (1994)](https://pubmed.ncbi.nlm.nih.gov/8087342/)
[Aktan F, iNOS-mediated nitric oxide production and its regulation (2004)](https://pubmed.ncbi.nlm.nih.gov/15158681/)
[Stewart VC, et al, iNOS expression in brain (2000)](https://pubmed.ncbi.nlm.nih.gov/10964188/)
[Huang Z, et al, Effects of iNOS deficiency in models of neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32380523/)
[Xie QW, et al, Cloning and characterization of iNOS (1992)](https://pubmed.ncbi.nlm.nih.gov/1373522/)
[Guix FX, et al, NO in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33491327/)
[Liu B, et al, iNOS in Parkinson's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36921628/)
[Saha RN, et al, iNOS in neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/30639743/)Pathway Diagram
The following diagram shows the key molecular relationships involving NOS2 - Nitric Oxide Synthase 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)